Molecule of the month. Vadimezan.
D000818:Animals; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D016896:Treatment Outcome; D044004:Xanthones / Q000009:adverse effects / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D044004:Xanthones; C066668:vadimezan